Rang	Name	Position
1	Dr. Neil Kumar Ph.D.	Co-Founder, CEO & Director
2	Dr. Thomas Trimarchi Ph.D.	CFO & President
3	Dr. Charles J. Homcy M.D.	Co-Founder, Chairman of Pharmaceuticals & Lead Director
4	Dr. Frank P. McCormick Ph.D.	Co-Founder, Chairman of Oncology & Director
5	Ms. Maricel M. Apuli	Chief Accounting Officer
6	Dr. Uma Sinha Ph.D.	Chief Scientific Officer
7	Dr. Richard H. Scheller Ph.D.	Chairman of Research & Development
8	Mr. Eli M. Wallace Ph.D.	Chief Scientific Officer of Oncology
9	Dr. Eric Michael David J.D., M.D., Ph.D.	Chief Executive Officer of Gene Therapy
10	Mr. Matthew Outten CPC, MBA	Chief Commercial Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Jupiter Topco LLC	7,22%	1,00 Mrd. USD
2	Kohlberg Kravis Roberts & Co LP	6,78%	0,94 Mrd. USD
3	HHG PLC	6,74%	0,93 Mrd. USD
4	Farallon Capital Management, L.L.C.	5,50%	0,76 Mrd. USD
5	BlackRock Inc	5,26%	0,73 Mrd. USD
6	Viking Global Investors LP	5,09%	0,71 Mrd. USD
7	Vanguard Capital Management, LLC	4,04%	0,56 Mrd. USD
8	Vanguard Portfolio Management, LLC	3,92%	0,54 Mrd. USD
9	Wellington Management Company LLP	2,72%	0,38 Mrd. USD
10	Two Sigma Investments LLC	2,42%	0,33 Mrd. USD
11	Aisling Capital Management LP	2,35%	0,33 Mrd. USD
12	State Street Corp	2,27%	0,31 Mrd. USD
13	Citadel Advisors Llc	1,92%	0,27 Mrd. USD
14	Amvescap Plc.	1,89%	0,26 Mrd. USD
15	D. E. Shaw & Co LP	1,86%	0,26 Mrd. USD
16	Geode Capital Management, LLC	1,75%	0,24 Mrd. USD
17	Jane Street Group LLC	1,50%	0,21 Mrd. USD
18	JPMorgan Chase & Co	1,23%	0,17 Mrd. USD
19	Adage Capital Partners Gp LLC	1,15%	0,16 Mrd. USD
20	Franklin Templeton Inc	1,11%	0,15 Mrd. USD